MREFX | TRZPX | MREFX / TRZPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 4 years | - |
Gain YTD | 11.111 | 8.682 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 108M | 873M | 12% |
Annual Yield % from dividends | 1.32 | 2.54 | 52% |
Returns for 1 year | 9.96 | 4.88 | 204% |
Returns for 3 years | 26.53 | 12.11 | 219% |
Returns for 5 years | 50.57 | N/A | - |
Returns for 10 years | 48.83 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 26.16 | N/A | N/A |
iShares Health Innovation Active ETF | |||
IBHI | 23.66 | -0.02 | -0.08% |
iShares iBonds 2029 Term HY & Inc ETF | |||
EWUS | 35.33 | -0.29 | -0.81% |
iShares MSCI United Kingdom Small-Cp ETF | |||
FDT | 57.64 | -0.62 | -1.07% |
First Trust Dev Mkts Ex-US AlphaDEX® ETF | |||
FDIS | 94.93 | -2.64 | -2.71% |
Fidelity MSCI Consumer Discret ETF |